However, for the MDA-MB-231 tumor xenograft mice administered EBP-Gd-DO3A and EBP-(Gd-DO3A)3, significant enhancement was observed in the tumor tissues at 2 h postinjection, and strong enhancement remained for at least 4 h after administration (Fig. 5A). Here, EBP is linked to neoplasm.